About Us

Our Mission is to fundamentally transform therapies for neurodegenerative disorders by harnessing human genetics and gene regulatory networks.

A Team of Experienced Leaders

Anne Urfer-Buchwalder, PhD

Anne Urfer-Buchwalder, PhD

Founder and President

Roman Urfer, PhD

Roman Urfer, PhD

Founder and Chief Executive Officer

Karoly Nikolich, PhD

Karoly Nikolich, PhD

Director

Paolo Pevarello, PhD

Paolo Pevarello, PhD

Medicinal Chemistry Advisor

Shaheen Sheik-Sadhal, JD

Shaheen Sheik-Sadhal, JD

General Counsel

Tom Digby, JD

Tom Digby, JD

Intellectual Property Strategy

Collaborators

We complement our highly relevant extensive experience in start-ups with a global network of specialized collaborator companies and thereby apply state-of-the art technologies to execute our program in a capital efficient way.

Investors

Nan Fung Life Sciences logo
Schaller-Nikolich Foundation logo

Selonterra is backed by venture capital seed funding and grants.

We are grateful to the Michael J. Fox Foundation, Nan Fung Life Sciences, the Schaller-Nikolich Foundation, and the private individuals who have supported our quest for better neurodegenerative diseases therapies.